Health
Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults – Medical Xpress
A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune re…
A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults. A report published today in the New England Journal of Medicine describes the findings from the study, which was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. SARS-CoV-2 is the virus that causes COVID-19 disease.
The experimental vaccine,…
-
Noosa News23 hours agoEastern states shivered through a chilly June, is a warmer winter still on the cards?
-
Noosa News19 hours agoEnsure voices are heard – Proctor
-
Noosa News22 hours agoHow a 3D printed aorta helped surgeons replace a ‘ticking time bomb’ inside a man’s chest
-
Noosa News21 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away